Etizolam Legality: Is Research of the Drug Allowed in the U.S.?

Etizolam is an unregulated drug in the USA with a number of potential therapeutic properties. In other countries where etizolam is approved as a prescription it is used for treating insomnia, anxiety, panic disorder, and depression. Several clinical trials showed that the drug is more effective than a placebo in relieving anxiety and depression symptoms. Effects of the medication is somewhat similar to that of benzodiazepenes (triazolam, lorazepam, and clonazepam).

Just like that of its benzondiazepene cousins, the drug has extreme abuse potential and has been used for recreational use. Making use of this drug to achieve a “high” can be fatal due to the impaired judgement it tends to cause. Furthermore, there’s an increase likelihood of facing an overdose when alcohol is mixed with etizolam.

Etizolam Legality: Side Effects

The side effects of the drug range from mild to moderate. This depends on the therapeutic dosage made for certain conditions. One commonly known effect of the drug is sleepiness (usually happening during daytime). Dosage requires strict monitoring due to fatal overdose risks. Etizolam is intended for short term use as it shares similar to the benzodiazepenes.

Long term effects caused by benzodiazepenes include drug addiction, aggressive behavior, night dreams, and temporary memory loss. Individuals who abruptly stop the intake of benzodiazepenes typically experience severe withdrawal symptoms (at times requiring hospitalization).

Multiple U.S. Studies

Based on several clinical observations, the drug profile of etizolam isn’t unlike that of profiles seen in benzodiazepenes, which have been prescribed frequently in the United States. These include Valium, Xanax, and Klonopin.

While etizolam on its own isn’t categorized as a benzeodiazepene, the effects it brought during a study for individuals suffering from anxiety disorders didn’t lead to any cognitive problems (the study was conduct on January 2013).

Furthermore, the study, which involved both sexes between twenty and sixty years of age, showcased that was brought about: a positive indicator for those suffering from insomnia.

In a separate study made on the drug, doctors studying etizolam legality showed a significant reduction in anxiety in a group of patients: the group diagnosed with generalized anxiety (and depression) were seen to have improved in the later stages of the trial by taking 0.5mg etizolam (one to three times daily). In addition, the study done previously showed how the drug was tolerated by those who took part in the study. Those same individuals also experienced minimal side effects.

Studies Over the Years

For the past several years, a majority of clinical trials (double blind, triple blind, and other types) have been done on etizolam. The drug has many names (Depas, Sedekopan, Etizola, and Pasaden) depending on where in the world they’re marketed and used for.

Currently, research is now being conducted on the use of etizolam. Time will only tell what researchers and doctors will conclude, although it’s a bit difficult to make an argument if etizolam legality aren’t as effective as those in tablet form.

Leave a Reply

Your email address will not be published. Required fields are marked *